When.com Web Search

  1. Ads

    related to: new congestive heart failure drugs

Search results

  1. Results From The WOW.Com Content Network
  2. Hydralazine/isosorbide dinitrate - Wikipedia

    en.wikipedia.org/wiki/Hydralazine/isosorbide_di...

    A new paper was published on these findings and MedCo filed for a new patent for the drug as a treatment for heart failure specifically in black patients. [ 4 ] [ 7 ] [ 8 ] The new patent and the old patent were then licensed to a company called NitroMed, which ran a clinical called the African-American Heart Failure Trial (A-HeFT), the results ...

  3. Amrinone - Wikipedia

    en.wikipedia.org/wiki/Amrinone

    Amrinone, also known as inamrinone, and sold as Inocor, is a pyridine phosphodiesterase 3 inhibitor. [1] It is a drug that may improve the prognosis in patients with congestive heart failure. [2]

  4. Cardiotonic agent - Wikipedia

    en.wikipedia.org/wiki/Cardiotonic_agent

    Drug examples General indications Common side effects Cautions Special populations Digoxin [8]. Digitalis [8]. Digitoxin [8]. Heart failure with reduced ejection fraction [9]. Atrial Fibrillation (abnormal heart rhythm) [9]

  5. Stem cell therapy to correct heart failure in children could ...

    www.aol.com/stem-cell-therapy-correct-heart...

    "Using stem cells from patients with heart failure caused by chemo, we are actively developing new drugs and cell-based treatments that we believe will transform the lives of patients with these ...

  6. Management of heart failure - Wikipedia

    en.wikipedia.org/wiki/Management_of_heart_failure

    People with heart failure, also known as congestive heart failure (CHF), are educated to undertake various non-pharmacological measures to improve symptoms and prognosis. Such measures include: [2] Moderate physical activity, when symptoms are mild or moderate; or bed rest when symptoms are severe. In individuals with heart failure, increasing ...

  7. Heart failure - Wikipedia

    en.wikipedia.org/wiki/Heart_failure

    Similarly, the ACC/AHA recommends against using COX-2 inhibitor medications in people with heart failure. [54] Thiazolidinediones have been strongly linked to new cases of heart failure and worsening of pre-existing congestive heart failure due to their association with weight gain and fluid retention. [54]

  1. Ads

    related to: new congestive heart failure drugs